Welltower to Participate in Evercore ISI Real Estate Conference
Welltower® Inc. announced that it will participate in the Evercore ISI Real Estate Conference to be held on September 11, 2020. In conjunction with the conference, Welltower has issued the following presentation which can be found at: https://welltower.com/evercore-isi-real-estate-conference About Welltower Welltower Inc., an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading … Continue reading Welltower to Participate in Evercore ISI Real Estate Conference Continue Reading
Lydian International Limited – in liquidation (“Lydian” or the “Company”) announced today that, by an order of the Royal Court of Jersey (the “Royal Court”) dated September 11, 2020 the winding up of the Company was approved pursuant to Article 155 of the Companies (Jersey) Law 1991 on a just and equitable basis (the “Just and Equitable … 
Halper Sadeh LLP, a global investor rights law firm, is investigating: National General Holdings Corp. concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to The Allstate Corporation. Under the terms of the proposed transaction, National General shareholders will receive $32.00 per share in cash and closing dividends expected to be $2.50 per share. Otelco … 
The nation’s top iBuyers bought 880 homes in the second quarter, or 0.1% of homes that sold across more than 400 U.S. metros, according to an analysis from Redfin (www.redfin.com), the tech-powered real estate brokerage. That is down 88% from 7,410 homes, or 0.6% market share, a year earlier and represents the smallest number of properties purchased … 
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until September 14, 2020 to file lead plaintiff applications in a securities class action lawsuit against Bayer Aktiengesellschaft – (OTC: BAYRY), if they purchased the Company’s American Depositary Receipts (“ADRs”) between May 23, 2016 and March 19, … 
89bio, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced that it has commenced an underwritten public offering of 3,000,000 shares of its common stock, which includes 2,700,000 shares of the common stock offered by the company and 300,000 shares …